相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca2+ signaling in Huntington's disease
Junghee Lee et al.
ACTA NEUROPATHOLOGICA (2013)
A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease
Beena Thomas et al.
ANALYTICAL BIOCHEMISTRY (2013)
Altered DNA methylation and RNA splicing could be key mechanisms in Huntington disease
Heather Wood
Nature Reviews Neurology (2013)
Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington's Disease
Izaskun Villar-Menendez et al.
NEUROMOLECULAR MEDICINE (2013)
Extensive changes in DNA methylation are associated with expression of mutant huntingtin
Christopher W. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
Dongbo Yu et al.
CELL (2012)
Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntingtons disease mice: implications for the ubiquitinproteasomal and autophagy systems
Haiqun Jia et al.
HUMAN MOLECULAR GENETICS (2012)
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
Haiqun Jia et al.
NEUROBIOLOGY OF DISEASE (2012)
Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease
Karen N. McFarland et al.
PLOS ONE (2012)
New insights into non-coding RNA networks in Huntington's disease
Noel J. Buckley et al.
EXPERIMENTAL NEUROLOGY (2011)
Altered microRNA regulation in Huntington's disease models
Soon-Tae Lee et al.
EXPERIMENTAL NEUROLOGY (2011)
Using non-coding small RNAs to develop therapies for Huntington's disease
Y. Zhang et al.
GENE THERAPY (2011)
Regulation of miR-146a by RelA/NFkB and p53 in STHdhQ111/HdhQ111 Cells, a Cell Model of Huntington's Disease
Jayeeta Ghose et al.
PLOS ONE (2011)
SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
Michal Mielcarek et al.
PLOS ONE (2011)
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse
Yi Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry
Erika N. Ebbel et al.
ANALYTICAL BIOCHEMISTRY (2010)
Epigenetic regulation in the pathophysiology of Alzheimer's disease
Leonidas Chouliaras et al.
PROGRESS IN NEUROBIOLOGY (2010)
Sustained Effects of Nonallele-Specific Huntingtin Silencing
Valerie Drouet et al.
ANNALS OF NEUROLOGY (2009)
Posttranscriptional Crossregulation between Drosha and DGCR8
Jinju Han et al.
CELL (2009)
A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference
Maria Stella Lombardi et al.
EXPERIMENTAL NEUROLOGY (2009)
Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
Ryan L. Boudreau et al.
MOLECULAR THERAPY (2009)
Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
Jiaxin Hu et al.
NATURE BIOTECHNOLOGY (2009)
Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation
Junghee Lee et al.
HUMAN MOLECULAR GENETICS (2008)
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease
Nicholas R. Franich et al.
MOLECULAR THERAPY (2008)
DNA methylation landscapes: provocative insights from epigenomics
Miho M. Suzuki et al.
NATURE REVIEWS GENETICS (2008)
A microRNA-based gene dysregulation pathway in Huntington's disease
Rory Johnson et al.
NEUROBIOLOGY OF DISEASE (2008)
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
Jodi L. McBride et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
Elizabeth A. Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Sodium phenylbutyrate in Huntington's disease: A dose-finding study
Penelope Hogarth et al.
MOVEMENT DISORDERS (2007)
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Ghazaleh Sadri-Vakili et al.
HUMAN MOLECULAR GENETICS (2007)
Modulation of nucleosome dynamics in Huntington's disease
Edward C. Stack et al.
HUMAN MOLECULAR GENETICS (2007)
Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation
Jim P. Dompierre et al.
JOURNAL OF NEUROSCIENCE (2007)
Epigenetics: A landscape takes shape
Aaron D. Goldberg et al.
CELL (2007)
High-capacity adenoviral vector-mediated reduction of Huntingtin aggregate load in vitro and in vivo
Bin Huang et al.
HUMAN GENE THERAPY (2007)
Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells
Jesus Espada et al.
NUCLEIC ACIDS RESEARCH (2007)
Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits
Ana M. M. Oliveira et al.
LEARNING & MEMORY (2007)
Heterochromatin revisited
Shiv I. S. Grewal et al.
NATURE REVIEWS GENETICS (2007)
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Hoon Ryu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons
Zhongfeng Wang et al.
NEURON (2006)
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse
Y Machida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Mechanisms of disease: histone modifications in Huntington's disease
Ghazaleh Sadri-Vakili et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
The therapeutic role of creatine in Huntington's disease
H Ryu et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice
E Rodriguez-Lebron et al.
MOLECULAR THERAPY (2005)
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease
BI Bae et al.
NEURON (2005)
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states
R Wu et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
G Gardian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Linking the epigenetic 'language' of covalent histone modifications to cancer
SB Hake et al.
BRITISH JOURNAL OF CANCER (2004)
Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells
M Jackson et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
E Trushina et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The Drosha-DGCR8 complex in primary microRNA processing
JJ Han et al.
GENES & DEVELOPMENT (2004)
Benefit of valproic acid in suppressing disease progression of ALS model mice
F Sugai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation
S Milutinovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2004)
Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration
JM Alarcón et al.
NEURON (2004)
CBP histone acetyltransferase activity is a critical component of memory consolidation
E Korzus et al.
NEURON (2004)
Experimental therapeutics in transgenic mouse models of Huntington's disease
MF Beal et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport
G Szebenyi et al.
NEURON (2003)
Mechanisms of transcriptional dysregulation in Huntington's disease
R Luthi-Carter et al.
CLINICAL NEUROSCIENCE RESEARCH (2003)
Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps
S Dasgupta et al.
JOURNAL OF IMMUNOLOGY (2003)
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation
S Igarashi et al.
NEUROREPORT (2003)
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
E Hockly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone methylation: Dynamic or static?
AJ Bannister et al.
CELL (2002)
Histone deacetylase inhibitors reduce polyglutamine toxicity
A McCampbell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells
MF Chan et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails
Y Zhang et al.
GENES & DEVELOPMENT (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
PA Marks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Acetylcholine-mediated modulation of striatal function
P Calabresi et al.
TRENDS IN NEUROSCIENCES (2000)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
分享论文
